We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
MetLife
MET
$61B
| $87.5K | 0.02% |
1,684
-2,991
| -64% | -$146K |
|
277
CALL
Rio Tinto
RIO
$148B
| $79.2K | 0.01% |
200
-331
| -62% | -$15.4K |
|
|
278
PUT
Rio Tinto
RIO
$148B
| $79.2K | 0.01% |
1,008
-159
| -14% | -$7.39K |
|
279
Advanced Micro Devices
AMD
$851B
| $79.1K | 0.01% |
+6,206
| New | +$81K |
|
280
CALL
Qiagen
QGEN
$8.53B
| $77.8K | 0.01% |
1,212
+863
| +247% | +$29.7K |
|
281
Boeing
BA
$165B
| $75K | 0.01% |
+295
| New | +$68.8K |
|
282
JetBlue
JBLU
$1.96B
| $74.8K | 0.01% |
+4,038
| New | +$84.6K |
|
283
Amgen
AMGN
$203B
| $74.6K | 0.01% |
400
-921
| -70% | -$163K |
|
284
American International
AIG
$41.9B
| $69.6K | 0.01% |
1,134
+359
| +46% | +$22.4K |
|
|
PX
285
DELISTED
Praxair Inc
PX
| $68.7K | 0.01% |
492
-334
| -40% | -$44.5K |
|
286
Equity Residential
EQR
$25.4B
| $66.6K | 0.01% |
1,010
+133
| +15% | +$8.9K |
|
|
RDUS
287
DELISTED
Radius Health, Inc.
RDUS
| $63.5K | 0.01% |
1,647
+1,599
| +3,331% | +$62.8K |
|
288
Uranium Energy
UEC
$4.71B
| $62.8K | 0.01% |
45,487
-13,535
| -23% | -$19.8K |
|
289
Cardinal Health
CAH
$53.4B
| $62.3K | 0.01% |
931
-261
| -22% | -$18.4K |
|
290
Simon Property Group
SPG
$74.5B
| $62.1K | 0.01% |
386
-120
| -24% | -$19.2K |
|
291
iShares MSCI Taiwan ETF
EWT
$10B
| $60.8K | 0.01% |
1,684
-911
| -35% | -$33.5K |
|
292
Hartford Financial Services
HIG
$38.5B
| $60.6K | 0.01% |
1,093
-38
| -3% | -$2.07K |
|
293
Nucor
NUE
$56.4B
| $60.5K | 0.01% |
1,080
-20
| -2% | -$1.13K |
|
294
iShares MSCI Japan ETF
EWJ
$21.6B
| $60K | 0.01% |
1,078
| – | – |
|
295
Ovintiv
OVV
$17.5B
| $59K | 0.01% |
1,000
| – | – |
|
296
O'Reilly Automotive
ORLY
$72.4B
| $57.7K | 0.01% |
+4,020
| New | +$53.1K |
|
297
ServiceNow
NOW
$102B
| $57.1K | 0.01% |
2,430
+2,365
| +3,638% | +$52.6K |
|
298
Baker Hughes
BKR
$56.8B
| $56.1K | 0.01% |
+1,531
| New | +$54.3K |
|
299
Eli Lilly
LLY
$1.07T
| $54.4K | 0.01% |
636
-3,055
| -83% | -$251K |
|
300
Royal Bank of Canada
RY
$291B
| $53.9K | 0.01% |
695
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.